What Every Cardiologist Should Know About the 2018 Updated Adult Congenital Cardiology Guidelines

Stephen J Dolgner1,2, Jonathan Buber3, Karen K Stout3

  • 1Division of Cardiology, Department of Medicine, University of Washington, Seattle, WA, USA. sdolgner@cardiology.washington.edu.

Current Cardiology Reports
|February 21, 2020
PubMed

Insights

The 2018 adult congenital heart disease (ACHD) guidelines offer a new classification system and emphasize available data. They provide fewer recommendations, highlighting the need for more research in ACHD management.

Area of Science:

  • Cardiology
  • Adult Congenital Heart Disease (ACHD) Management

Background:

  • Adult congenital heart disease (ACHD) requires specialized management strategies.
  • Previous guidelines relied heavily on expert opinion due to limited outcome data.

Purpose of the Study:

  • To review the updated 2018 guidelines for ACHD patient management.
  • To identify key changes from prior guidelines.

Main Methods:

  • Analysis of the 2018 ACHD management guidelines.
  • Comparison of the 2018 guidelines with previous recommendations.

Main Results:

  • Introduction of a new classification scheme integrating anatomy, residual disease, and symptoms.
  • Reduced number of recommendations compared to prior guidelines.
  • Emphasis on evidence-based recommendations and identification of data gaps.

Conclusions:

  • The 2018 guidelines represent a comprehensive update for ACHD management.
  • The updated guidelines prioritize available data and acknowledge areas needing further research.
Abstract

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
423
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
249
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
861
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
466
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
299
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
241